Neuromuscular Disorders

Curriculum Reference

14.8.3 Applies the principles of shared decision making about the suitability of surgery and anaesthesia with high-risk patients and colleagues.

14.9.2 Applies understanding of co-morbidities in patients requiring general anaesthesia and delivers management strategies to offer individualised care.

HiLLO 12: Doctors specialising in Intensive Care Medicine understand the special needs of, and are competent to manage patients with neurological diseases, both medical and those requiring surgery, which will include the management of raised intracranial pressure, central nervous system infections and neuromuscular disorders.

SSM NICU: Can recognise, resuscitate and initiate treatment of the patient with acute neurological injury, having an enhanced understanding of the specific neuropathophysiologies. They will be able to institute advanced pharmacological and physical therapeutic interventions, and continue ongoing diagnostic and disease management strategies, including multi-organ support.

Publications

Perioperative management of myasthenia gravis – BJA Education

Parkinson’s disease – BJA Education

Please note the following two resources may require a personal login
Neuromuscular disorders and anaesthesia. Part 1: generic anaesthetic management Continuing Education in Anaesthesia Critical Care & Pain,

Neuromuscular disorders and anaesthesia. Part 2: specific neuromuscular disorders Continuing Education in Anaesthesia Critical Care & Pain

Diagnosis and management of Guillain-Barre syndrome in ten steps – Nature Reviews Neurology Intensive Care and Treatment of Severe Guillain–Barré Syndrome

National Guidance/Standards

AssAssociation of British Neurologists – Guidelines for the management of myasthenia gravis

Myotonic Dystrophy Association (Myotonic.org) Anaesthesia guidelines

RCoA Audit Compendium

FICM recommendation

The management of patients with ventilatory insufficiency due to neuromuscular disease should follow BTS/ICS guidelines.

The management of decompensated acute inflammatory neuropathy should follow best practice guidance.